Advagene Biopharma (Taiwan) Today

6709 Stock  TWD 18.40  1.40  8.24%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak
Advagene Biopharma is selling for under 18.40 as of the 25th of April 2024; that is 8.24 percent increase since the beginning of the trading day. The stock's lowest day price was 17.25. Advagene Biopharma has 50 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. Equity ratings for Advagene Biopharma Co are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of March 2024 and ending today, the 25th of April 2024. Click here to learn more.

Advagene Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Advagene Biopharma's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Advagene Biopharma or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Chairman of the BoardBryon Chen
Advagene Biopharma Co (6709) is traded on Taiwan OTC Exchange in Taiwan and employs 10 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 879.46 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Advagene Biopharma's market, we take the total number of its shares issued and multiply it by Advagene Biopharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.
Check Advagene Biopharma Probability Of Bankruptcy

Advagene Stock Price Odds Analysis

Depending on a normal probability distribution, the odds of Advagene Biopharma jumping above the current price in 90 days from now is about 85.95%. The Advagene Biopharma Co probability density function shows the probability of Advagene Biopharma stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Advagene Biopharma has a beta of 0.1823. This suggests as returns on the market go up, Advagene Biopharma average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Advagene Biopharma Co will be expected to be much smaller as well. Additionally, advagene Biopharma Co has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
  Odds Below 18.4HorizonTargetOdds Above 18.4
13.99%90 days
 18.40 
85.95%
Based on a normal probability distribution, the odds of Advagene Biopharma to move above the current price in 90 days from now is about 85.95 (This Advagene Biopharma Co probability density function shows the probability of Advagene Stock to fall within a particular range of prices over 90 days) .

Advagene Biopharma Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Advagene Biopharma market risk premium is the additional return an investor will receive from holding Advagene Biopharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Advagene Biopharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Advagene Biopharma's alpha and beta are two of the key measurements used to evaluate Advagene Biopharma's performance over the market, the standard measures of volatility play an important role as well.

Advagene Biopharma Technical Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Advagene Biopharma Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Advagene Biopharma price patterns.

Advagene Stock Against Markets

Picking the right benchmark for Advagene Biopharma stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Advagene Biopharma stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Advagene Biopharma is critical whether you are bullish or bearish towards Advagene Biopharma Co at a given time. Please also check how Advagene Biopharma's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Advagene Biopharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Bond Analysis Now

   

Bond Analysis

Evaluate and analyze corporate bonds as a potential investment for your portfolios.
All  Next Launch Module

How to buy Advagene Stock?

Before investing in Advagene Biopharma, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Advagene Biopharma. To buy Advagene Biopharma stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Advagene Biopharma. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Advagene Biopharma stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Advagene Biopharma Co stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Advagene Biopharma Co stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Advagene Biopharma Co, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.

Already Invested in Advagene Biopharma Co?

The danger of trading Advagene Biopharma Co is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Advagene Biopharma is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Advagene Biopharma. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Advagene Biopharma is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Advagene Biopharma Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Complementary Tools for Advagene Stock analysis

When running Advagene Biopharma's price analysis, check to measure Advagene Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Advagene Biopharma is operating at the current time. Most of Advagene Biopharma's value examination focuses on studying past and present price action to predict the probability of Advagene Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Advagene Biopharma's price. Additionally, you may evaluate how the addition of Advagene Biopharma to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Money Managers
Screen money managers from public funds and ETFs managed around the world
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Please note, there is a significant difference between Advagene Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Advagene Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Advagene Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.